Skip to main content

Table 1 Baseline characteristics

From: A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism

 

Placebo (n = 19, 13 males, 6 females)

Omega (n = 18, 14 males, 4 females)

 

Mean (minimum-maximum)

95% CL for mean

Mean (minimum-maximum)

95% CL for mean

Age (years)

3.5 (2.0 to 6.0)

3.0 to 4.0

3.9 (2.0 to 4.2)

3.4 to 4.4

ADOS

    

  Communication (C)

5.5 (3.0 to 9.0)

4.6 to 6.5

5.5 (1.0 to 8.0)

4.6 to 6.5

  Social interaction (SI)

9.5 (6.0 to 14.0)

8.4 to 10.6

10.7 (4.0 to 14.0)

9.2 to 12.1

  Communication (C) + social interaction (SI)

15.0 (9.0 to 22.0)

13.1 to 16.9

15.2 (5.0 to 22.0)

12.5 to 17.9

ADI-R

    

  Communication

17.2 (5.0 to 28.0)

14.3 to 20.1

19.4 (9.0 to 29.0)

16.7 to 22.2

  Social interaction

12.5 (7.0 to 23.0)

10.5 to 14.5

12.8 (9.0 to 20.0)

11.4 to 14.2

  Play

6.2 (2.0 to 10.0)

5.1 to 7.2

5.6 (2.0 to 10.0)

4.7 to 6.4

  Stereotyped behavior

4.1 (3.0 to 5.0)

3.7 to 4.5

4.1 (1.0 to 5.0)

3.6 to 4.6

Mullen scales of early learning-AGS

    

  Visual reception

30.8 (20.0 to 63.0)

23.5 to 38.2

31.7 (19.0 to 65.0)

24.3 to 39.1

  Fine motor

28.3 (19.0 to 65.0)

21.9 to 34.6

23.6 (19.0 to 41.0)

20.2 to 27.1

  Receptive language

28.8 (19.0 to 56.0)

22.4 to 35.1

27.6 (19.0 to 62.0)

21.5 to 33.7

  Expressive language

26.8 (19.0 to 44.0)

22.8 to 30.8

25.7 (19.0 to 45.0)

21.2 to 30.3

  Blood omega levels

4.7 (3.4 to 6.2)

4.1 to 5.3

5.5 (3.9 to 8.2)

4.5 to 6.6